Conquering Diseases

Study Of An Investigational Drug For Covid-19 In Hospitalized Children

Description

Seeking boys and girls under the age of 18 who are hospitalized for a COVID-19 infection for a study of the safety and effectiveness of an investigational drug.

Overview

We are studying the safety and effectiveness of an investigational drug for children hospitalized with COVID-19. The investigational drug has been approved for use in adults, but has not been studied in children.

What we're hoping for

We hope that the investigational drug will be safe and effective for use in children hospitalized with COVID-19. We also hope to find the best dose of the investigational drug.

Additional Information

ClinicalTrials.gov Identifier: NCT04431453

 Principal Investigator

Katherine  Luzuriaga, MD

University of Massachusetts Medical School

 Study Contact

The Clinical Research  Center

508-856-2800

clinicaltrialsunit@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989